Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosis is a research paper published in Journal of Cystic Fibrosis (2023). On theSindex it has a DataRank of 1.0. It has been cited 31 times, with 25 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0.511
From 17 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 25 citers.
BHF Centre of Research Excellence, Oxford
Grant: P30 DK072482
BHF Centre of Research Excellence, Oxford
Grant: UL1 TR003098
NIDDK NIH HHS
Grant: P30 DK065988
NIEHS NIH HHS
Grant: P30 ES010126
AstraZeneca
National Institute of Diabetes and Digestive and Kidney Diseases
Cystic Fibrosis Foundation
FWCI
5.13
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals